speb/financial-data huggingface dataset:
CCJ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3218195000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3218195000.00
CCJ balance_sheet (annual, 2025-12-31) — Minority Interest: 15000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Minority Interest: 15000.00
CCJ income_statement (annual, 2025-12-31) — Minority Interests: 35000.00
CCJ income_statement (quarterly, 2025-12-31) — Minority Interests: 3000.00
CCJ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2170000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 773000.00
CCJ cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 61740000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 1611000.00
CCJ income_statement (annual, 2025-12-31) — Net Income: 589577000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income: 199066000.00
CCJ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 589577000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 199066000.00
CCJ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 589542000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 199063000.00
CCJ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 589577000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 199066000.00
CCJ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 589577000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 199066000.00
CCJ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 589542000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 199063000.00
CCJ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 589542000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 199063000.00
CCJ income_statement (annual, 2025-12-31) — Net Interest Income: -92003000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Interest Income: -52663000.00
CCJ cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -99603000.00
CCJ cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -287973000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -375000.00
CCJ cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -287973000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -375000.00
CCJ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -92003000.00
CCJ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -52663000.00
CCJ cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1137000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
CCJ balance_sheet (annual, 2025-12-31) — Net PPE: 3325077000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Net PPE: 3325077000.00
CCJ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -332780000.00
CCJ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -109000000.00
CCJ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6867201000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6867201000.00
CCJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 666457000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 666457000.00
CCJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 666457000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 666457000.00
CCJ income_statement (annual, 2025-12-31) — Normalized EBITDA: 1135914000.00
CCJ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 364456000.00
CCJ income_statement (annual, 2025-12-31) — Normalized Income: 566701046.21
CCJ income_statement (quarterly, 2025-12-31) — Normalized Income: 180228828.05
CCJ cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1408432000.00
CCJ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 677325000.00
CCJ cash_flow (annual, 2025-12-31) — Operating Gains Losses: -297280000.00
CCJ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -103622000.00
CCJ income_statement (annual, 2025-12-31) — Operating Income: 621259000.00
CCJ income_statement (quarterly, 2025-12-31) — Operating Income: 204322000.00
CCJ income_statement (annual, 2025-12-31) — Operating Revenue: 3481933000.00
CCJ income_statement (quarterly, 2025-12-31) — Operating Revenue: 1200930000.00
CCJ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 435457978.00
CCJ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 435457978.00
CCJ balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 134667000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 134667000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Equity Interest: 144938000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 144938000.00
CCJ income_statement (annual, 2025-12-31) — Other Gand A: 311250000.00
CCJ income_statement (quarterly, 2025-12-31) — Other Gand A: 88495000.00
CCJ income_statement (annual, 2025-12-31) — Other Income Expense: 248005000.00
CCJ income_statement (quarterly, 2025-12-31) — Other Income Expense: 94766000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 36162000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 36162000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Inventories: 2358000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Inventories: 2358000.00
CCJ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8951000.00
CCJ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 17014000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 647245000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 647245000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 377955000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 377955000.00
CCJ income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1459000.00
CCJ income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 340000.00
CCJ income_statement (annual, 2025-12-31) — Other Operating Expenses: -703000.00
CCJ income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -34931000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Payable: 127054000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Payable: 127054000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Properties: 290000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Properties: 290000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Receivables: 44686000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Receivables: 44686000.00
CCJ balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 99603000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 99603000.00
CCJ balance_sheet (annual, 2025-12-31) — Payables: 887871000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Payables: 887871000.00
CCJ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 887871000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 887871000.00
CCJ income_statement (annual, 2025-12-31) — Pretax Income: 777261000.00
CCJ income_statement (quarterly, 2025-12-31) — Pretax Income: 246425000.00
CCJ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -333025000.00
CCJ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -109134000.00
CCJ balance_sheet (annual, 2025-12-31) — Raw Materials: 829591000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Raw Materials: 829591000.00
CCJ balance_sheet (annual, 2025-12-31) — Receivables: 411424000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Receivables: 411424000.00
CCJ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2511660000.00
CCJ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 928133000.00
CCJ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 293094000.00
CCJ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 86912000.00
CCJ cash_flow (annual, 2025-12-31) — Repayment Of Debt: -287973000.00
CCJ cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -375000.00
CCJ income_statement (annual, 2025-12-31) — Research And Development: 38467000.00
CCJ income_statement (quarterly, 2025-12-31) — Research And Development: 14911000.00
CCJ balance_sheet (annual, 2025-12-31) — Retained Earnings: 3608778000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3608778000.00
CCJ cash_flow (annual, 2025-12-31) — Sale Of PPE: 245000.00
CCJ cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 134000.00
CCJ income_statement (annual, 2025-12-31) — Selling General And Administration: 311250000.00
CCJ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 88495000.00
CCJ balance_sheet (annual, 2025-12-31) — Share Issued: 435457978.00
CCJ balance_sheet (quarterly, 2025-12-31) — Share Issued: 435457978.00
CCJ income_statement (annual, 2025-12-31) — Special Income Charges: -3117000.00
CCJ income_statement (quarterly, 2025-12-31) — Special Income Charges: -1091000.00
CCJ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 9656000.00
CCJ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2759000.00
CCJ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6903363000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6903363000.00
CCJ balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6867201000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6867201000.00
CCJ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 7284046.21
CCJ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 4481828.05
CCJ income_statement (annual, 2025-12-31) — Tax Provision: 187719000.00
CCJ income_statement (quarterly, 2025-12-31) — Tax Provision: 47362000.00
CCJ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CCJ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
CCJ balance_sheet (annual, 2025-12-31) — Taxes Receivable: 28312000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 28312000.00
CCJ cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -90206000.00
CCJ cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -10362000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Assets: 10301282000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Assets: 10301282000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Capitalization: 7899711000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7899711000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Debt: 996348000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Debt: 996348000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6903378000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6903378000.00
CCJ income_statement (annual, 2025-12-31) — Total Expenses: 2860674000.00
CCJ income_statement (quarterly, 2025-12-31) — Total Expenses: 996608000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3397904000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3397904000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7662067000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7662067000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2327718000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2327718000.00
CCJ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 618142000.00
CCJ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 173341000.00
CCJ income_statement (annual, 2025-12-31) — Total Other Finance Cost: 19456000.00
CCJ income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 5494000.00
CCJ balance_sheet (annual, 2025-12-31) — Total Tax Payable: 16516000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 16516000.00
CCJ income_statement (annual, 2025-12-31) — Total Unusual Items: 30160000.00
CCJ income_statement (quarterly, 2025-12-31) — Total Unusual Items: 23319000.00
CCJ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 30160000.00
CCJ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 23319000.00
CCJ balance_sheet (annual, 2025-12-31) — Working Capital: 1569029000.00
CCJ balance_sheet (quarterly, 2025-12-31) — Working Capital: 1569029000.00
CCJ income_statement (quarterly, 2026-03-31) — +Operating Expense: 137436000.00
CCJ income_statement (quarterly, 2026-03-31) — +Total Revenue: 845365000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 440442000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 180302000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 187935000.00
CCJ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 435529000.00
CCJ income_statement (quarterly, 2026-03-31) — Basic EPS: 0.30
CCJ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1114860000.00
CCJ cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -77739000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2939763000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1075117000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1109720000.00
CCJ cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
CCJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -4380000.00
CCJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -12739000.00
CCJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -22276000.00
CCJ cash_flow (quarterly, 2026-03-31) — Change In Inventory: 124181000.00
CCJ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -456078000.00
CCJ cash_flow (quarterly, 2026-03-31) — Change In Receivables: 190820000.00
CCJ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -141077000.00
CCJ cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 190820000.00
CCJ cash_flow (quarterly, 2026-03-31) — Changes In Cash: -39395000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Common Stock: 2939763000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7064532000.00
CCJ cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1146000.00
CCJ income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 543781000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Current Assets: 2237730000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 727034000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Current Provisions: 57935000.00
CCJ cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 32152000.00
CCJ cash_flow (quarterly, 2026-03-31) — Deferred Tax: 32152000.00
CCJ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 67097000.00
CCJ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 67097000.00
CCJ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 435632000.00
CCJ income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.30
CCJ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 130751000.00
CCJ cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 67507000.00
CCJ income_statement (quarterly, 2026-03-31) — EBIT: 185656000.00
CCJ income_statement (quarterly, 2026-03-31) — EBITDA: 252753000.00
CCJ income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 54466000.00
CCJ cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -54466000.00
CCJ cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -348000.00
CCJ cash_flow (quarterly, 2026-03-31) — End Cash Position: 1075117000.00
CCJ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -4380000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Finished Goods: 204264000.00
CCJ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -100015000.00
CCJ cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 44147000.00
CCJ income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -313000.00
CCJ income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -37764000.00
CCJ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 122456000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 35204000.00
CCJ income_statement (quarterly, 2026-03-31) — Gross Profit: 301584000.00
CCJ income_statement (quarterly, 2026-03-31) — Interest Expense: 22754000.00
CCJ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 22754000.00
CCJ income_statement (quarterly, 2026-03-31) — Interest Income: 9993000.00
CCJ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 9993000.00
CCJ cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -4849000.00
CCJ cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 9993000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Inventory: 899344000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8061081000.00
CCJ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -12739000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 3018226000.00
CCJ cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1146000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 996549000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 996549000.00
CCJ cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -677000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 3018226000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 963516000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Minority Interest: 14000.00
CCJ income_statement (quarterly, 2026-03-31) — Minority Interests: 1000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1146000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -9961000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income: 130751000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 130751000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 130750000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 130751000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 130751000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 130750000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 130750000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Interest Income: -17994000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 65000000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -677000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -677000.00
CCJ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -17994000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Net PPE: 3360763000.00
CCJ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -77739000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7029328000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 635699000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 635699000.00
CCJ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 290830000.00
CCJ income_statement (quarterly, 2026-03-31) — Normalized Income: 161312734.97
CCJ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -22276000.00
CCJ cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -19967000.00
CCJ income_statement (quarterly, 2026-03-31) — Operating Income: 164148000.00
CCJ income_statement (quarterly, 2026-03-31) — Operating Revenue: 845365000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 435532978.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 205267000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 197309000.00
CCJ income_statement (quarterly, 2026-03-31) — Other Gand A: 122456000.00
CCJ income_statement (quarterly, 2026-03-31) — Other Income Expense: 16748000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Inventories: 3766000.00
CCJ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6238000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 817864000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 353841000.00
CCJ income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 359000.00
CCJ income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1077000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Receivables: 33304000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 34603000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Payables: 463832000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 463832000.00
CCJ income_statement (quarterly, 2026-03-31) — Pretax Income: 162902000.00
CCJ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -77739000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Raw Materials: 691314000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Receivables: 228666000.00
CCJ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 543781000.00
CCJ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 67097000.00
CCJ cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -677000.00
CCJ income_statement (quarterly, 2026-03-31) — Research And Development: 13903000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3739525000.00
CCJ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 65000000.00
CCJ cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CCJ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 122456000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Share Issued: 435532978.00
CCJ income_statement (quarterly, 2026-03-31) — Special Income Charges: -313000.00
CCJ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2855000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7064532000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7029328000.00
CCJ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -7515265.03
CCJ income_statement (quarterly, 2026-03-31) — Tax Provision: 32152000.00
CCJ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
CCJ balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 15060000.00
CCJ cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -177824000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Assets: 10105486000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8061081000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Debt: 996549000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7064546000.00
CCJ income_statement (quarterly, 2026-03-31) — Total Expenses: 681217000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3040940000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7867756000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2313906000.00
CCJ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 163835000.00
CCJ income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 5233000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 23390000.00
CCJ income_statement (quarterly, 2026-03-31) — Total Unusual Items: -38077000.00
CCJ income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -38077000.00
CCJ balance_sheet (quarterly, 2026-03-31) — Working Capital: 1510696000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Derivative Product Liabilities: 738000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Fixed Assets Revaluation Reserve: 26628000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Invested Capital: 222918000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Long Term Debt And Capital Lease Obligation: 48000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Net Debt: 48000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Total Capitalization: 222918000.00
CCJI.L balance_sheet (annual, 2021-10-31) — Total Debt: 48000.00
CCJI.L income_statement (annual, 2022-10-31) — +Operating Expense: 895000.00
CCJI.L income_statement (annual, 2022-10-31) — +Total Revenue: -11105000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Accounts Payable: 1933000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L income_statement (annual, 2022-10-31) — Basic Average Shares: 134730610.00
CCJI.L income_statement (annual, 2022-10-31) — Basic EPS: -0.10
CCJI.L cash_flow (annual, 2022-10-31) — Beginning Cash Position: -48000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Cash And Cash Equivalents: 1413000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Cash Cash Equivalents And Federal Funds Sold: 1846000.00
CCJI.L cash_flow (annual, 2022-10-31) — Cash Dividends Paid: -6400000.00
CCJI.L cash_flow (annual, 2022-10-31) — Change In Other Current Liabilities: 0.00
CCJI.L cash_flow (annual, 2022-10-31) — Change In Payable: 3000.00
CCJI.L cash_flow (annual, 2022-10-31) — Change In Receivables: -6000.00
CCJI.L cash_flow (annual, 2022-10-31) — Change In Working Capital: -3000.00
CCJI.L cash_flow (annual, 2022-10-31) — Changes In Cash: 1461000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Common Stock: 1348000.00
CCJI.L cash_flow (annual, 2022-10-31) — Common Stock Dividend Paid: -6400000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Common Stock Equity: 203582000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Derivative Product Liabilities: 2780000.00
CCJI.L income_statement (annual, 2022-10-31) — Diluted Average Shares: 161676732.00
CCJI.L income_statement (annual, 2022-10-31) — Diluted EPS: -0.10
CCJI.L income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: -12888000.00
CCJI.L cash_flow (annual, 2022-10-31) — End Cash Position: 1413000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 199642000.00
CCJI.L cash_flow (annual, 2022-10-31) — Financing Cash Flow: -6654000.00
CCJI.L cash_flow (annual, 2022-10-31) — Free Cash Flow: 5007000.00
CCJI.L cash_flow (annual, 2022-10-31) — Gain Loss On Investment Securities: 17644000.00
CCJI.L income_statement (annual, 2022-10-31) — Gain On Sale Of Security: 2474000.00
CCJI.L income_statement (annual, 2022-10-31) — General And Administrative Expense: 664000.00
CCJI.L income_statement (annual, 2022-10-31) — Interest Expense: 23000.00
CCJI.L income_statement (annual, 2022-10-31) — Interest Income: 0.00
CCJI.L cash_flow (annual, 2022-10-31) — Interest Paid Cff: -254000.00
CCJI.L cash_flow (annual, 2022-10-31) — Investing Cash Flow: 3108000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Investmentin Financial Assets: 199642000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Investments And Advances: 199642000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income: -12888000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income Common Stockholders: -12888000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income Continuous Operations: -12888000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: -12888000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: -12888000.00
CCJI.L cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: -11746000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: -12888000.00
CCJI.L income_statement (annual, 2022-10-31) — Net Interest Income: -23000.00
CCJI.L cash_flow (annual, 2022-10-31) — Net Investment Purchase And Sale: 3108000.00
CCJI.L cash_flow (annual, 2022-10-31) — Net Other Financing Charges: 0.00
CCJI.L cash_flow (annual, 2022-10-31) — Net Other Investing Changes: -184000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 203582000.00
CCJI.L income_statement (annual, 2022-10-31) — Normalized Income: -12888000.00
CCJI.L cash_flow (annual, 2022-10-31) — Operating Cash Flow: 5007000.00
CCJI.L income_statement (annual, 2022-10-31) — Operating Revenue: -11105000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 134730610.00
CCJI.L income_statement (annual, 2022-10-31) — Other Operating Expenses: 231000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Other Payable: 2780000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Payables: 4713000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Prepaid Assets: 42000.00
CCJI.L income_statement (annual, 2022-10-31) — Pretax Income: -12000000.00
CCJI.L cash_flow (annual, 2022-10-31) — Purchase Of Investment: -43756000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Receivables: 7010000.00
CCJI.L cash_flow (annual, 2022-10-31) — Sale Of Investment: 46864000.00
CCJI.L income_statement (annual, 2022-10-31) — Selling General And Administration: 664000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Share Issued: 134730610.00
CCJI.L balance_sheet (annual, 2022-10-31) — Stockholders Equity: 203582000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Tangible Book Value: 203582000.00
CCJI.L income_statement (annual, 2022-10-31) — Tax Effect Of Unusual Items: 0.00
CCJI.L income_statement (annual, 2022-10-31) — Tax Provision: 888000.00
CCJI.L income_statement (annual, 2022-10-31) — Tax Rate For Calcs: 0.19
CCJI.L balance_sheet (annual, 2022-10-31) — Taxes Receivable: 62000.00
CCJI.L cash_flow (annual, 2022-10-31) — Taxes Refund Paid: -888000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Total Assets: 208602000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Total Equity Gross Minority Interest: 203582000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Total Liabilities Net Minority Interest: 5020000.00
CCJI.L balance_sheet (annual, 2022-10-31) — Treasury Shares Number: 0.00
CCJI.L income_statement (annual, 2023-10-31) — +Operating Expense: 931000.00
CCJI.L income_statement (annual, 2023-10-31) — +Total Revenue: 40192000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Accounts Payable: 200000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L income_statement (annual, 2023-10-31) — Basic Average Shares: 134730610.00
CCJI.L income_statement (annual, 2023-10-31) — Basic EPS: 0.28
CCJI.L cash_flow (annual, 2023-10-31) — Beginning Cash Position: 1413000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Cash And Cash Equivalents: 340000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Cash Cash Equivalents And Federal Funds Sold: 1146000.00
CCJI.L cash_flow (annual, 2023-10-31) — Cash Dividends Paid: -6804000.00
CCJI.L cash_flow (annual, 2023-10-31) — Change In Other Current Liabilities: 0.00
CCJI.L cash_flow (annual, 2023-10-31) — Change In Payable: 19000.00
CCJI.L cash_flow (annual, 2023-10-31) — Change In Receivables: -500000.00
CCJI.L cash_flow (annual, 2023-10-31) — Change In Working Capital: -481000.00
CCJI.L cash_flow (annual, 2023-10-31) — Changes In Cash: -1073000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Common Stock: 1348000.00
CCJI.L cash_flow (annual, 2023-10-31) — Common Stock Dividend Paid: -6804000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Common Stock Equity: 235118000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Derivative Product Liabilities: 738000.00
CCJI.L income_statement (annual, 2023-10-31) — Diluted Average Shares: 134730610.00
CCJI.L income_statement (annual, 2023-10-31) — Diluted EPS: 0.28
CCJI.L income_statement (annual, 2023-10-31) — Diluted NI Availto Com Stockholders: 38340000.00
CCJI.L cash_flow (annual, 2023-10-31) — End Cash Position: 340000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 231987000.00
CCJI.L cash_flow (annual, 2023-10-31) — Financing Cash Flow: -7032000.00
CCJI.L cash_flow (annual, 2023-10-31) — Free Cash Flow: 6513000.00
CCJI.L cash_flow (annual, 2023-10-31) — Gain Loss On Investment Securities: -31582000.00
CCJI.L income_statement (annual, 2023-10-31) — Gain On Sale Of Security: 13505000.00
CCJI.L income_statement (annual, 2023-10-31) — General And Administrative Expense: 715000.00
CCJI.L income_statement (annual, 2023-10-31) — Interest Expense: 20000.00
CCJI.L income_statement (annual, 2023-10-31) — Interest Income: 68000.00
CCJI.L cash_flow (annual, 2023-10-31) — Interest Paid Cff: -228000.00
CCJI.L cash_flow (annual, 2023-10-31) — Investing Cash Flow: -554000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Investmentin Financial Assets: 231987000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Investments And Advances: 231987000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income: 38340000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income Common Stockholders: 38340000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income Continuous Operations: 38340000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income From Continuing And Discontinued Operation: 38340000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income From Continuing Operation Net Minority Interest: 38340000.00
CCJI.L cash_flow (annual, 2023-10-31) — Net Income From Continuing Operations: 39497000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Income Including Noncontrolling Interests: 38340000.00
CCJI.L income_statement (annual, 2023-10-31) — Net Interest Income: 48000.00
CCJI.L cash_flow (annual, 2023-10-31) — Net Investment Purchase And Sale: -554000.00
CCJI.L cash_flow (annual, 2023-10-31) — Net Other Financing Charges: 0.00
CCJI.L cash_flow (annual, 2023-10-31) — Net Other Investing Changes: 7656000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Net Tangible Assets: 235118000.00
CCJI.L income_statement (annual, 2023-10-31) — Normalized Income: 38340000.00
CCJI.L cash_flow (annual, 2023-10-31) — Operating Cash Flow: 6513000.00
CCJI.L income_statement (annual, 2023-10-31) — Operating Revenue: 40192000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Ordinary Shares Number: 134730610.00
CCJI.L income_statement (annual, 2023-10-31) — Other Operating Expenses: 216000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Other Payable: 738000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Payables: 938000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Prepaid Assets: 70000.00
CCJI.L income_statement (annual, 2023-10-31) — Pretax Income: 39261000.00
CCJI.L cash_flow (annual, 2023-10-31) — Purchase Of Investment: -57623000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Receivables: 4325000.00
CCJI.L cash_flow (annual, 2023-10-31) — Sale Of Investment: 57069000.00
CCJI.L income_statement (annual, 2023-10-31) — Selling General And Administration: 715000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Share Issued: 134730610.00
CCJI.L balance_sheet (annual, 2023-10-31) — Stockholders Equity: 235118000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Tangible Book Value: 235118000.00
CCJI.L income_statement (annual, 2023-10-31) — Tax Effect Of Unusual Items: 0.00
CCJI.L income_statement (annual, 2023-10-31) — Tax Provision: 921000.00
CCJI.L income_statement (annual, 2023-10-31) — Tax Rate For Calcs: 0.02
CCJI.L balance_sheet (annual, 2023-10-31) — Taxes Receivable: 128000.00
CCJI.L cash_flow (annual, 2023-10-31) — Taxes Refund Paid: -921000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Total Assets: 237656000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 235118000.00
CCJI.L balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 2538000.00
CCJI.L income_statement (annual, 2024-10-31) — +Operating Expense: 1051000.00
CCJI.L income_statement (annual, 2024-10-31) — +Total Revenue: 39910000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Accounts Payable: 0.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 0.00
CCJI.L balance_sheet (annual, 2024-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L income_statement (annual, 2024-10-31) — Basic Average Shares: 134730610.00
CCJI.L income_statement (annual, 2024-10-31) — Basic EPS: 0.28
CCJI.L cash_flow (annual, 2024-10-31) — Beginning Cash Position: 340000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Cash And Cash Equivalents: 4006000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Cash And Cash Equivalents: 4006000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 4419000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 4419000.00
CCJI.L cash_flow (annual, 2024-10-31) — Cash Dividends Paid: -7208000.00
CCJI.L cash_flow (annual, 2024-10-31) — Change In Other Current Liabilities: 0.00
CCJI.L cash_flow (annual, 2024-10-31) — Change In Payable: -52000.00
CCJI.L cash_flow (annual, 2024-10-31) — Change In Receivables: -73000.00
CCJI.L cash_flow (annual, 2024-10-31) — Change In Working Capital: -125000.00
CCJI.L cash_flow (annual, 2024-10-31) — Changes In Cash: 3666000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Common Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Common Stock: 1348000.00
CCJI.L cash_flow (annual, 2024-10-31) — Common Stock Dividend Paid: -7208000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Common Stock Equity: 265841000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 265841000.00
CCJI.L income_statement (annual, 2024-10-31) — Diluted Average Shares: 134730610.00
CCJI.L income_statement (annual, 2024-10-31) — Diluted EPS: 0.28
CCJI.L income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 37931000.00
CCJI.L cash_flow (annual, 2024-10-31) — End Cash Position: 4006000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 258478000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 258478000.00
CCJI.L cash_flow (annual, 2024-10-31) — Financing Cash Flow: -7530000.00
CCJI.L cash_flow (annual, 2024-10-31) — Free Cash Flow: 11672000.00
CCJI.L cash_flow (annual, 2024-10-31) — Gain Loss On Investment Securities: -26465000.00
CCJI.L income_statement (annual, 2024-10-31) — Gain On Sale Of Security: 15532000.00
CCJI.L income_statement (annual, 2024-10-31) — General And Administrative Expense: 759000.00
CCJI.L income_statement (annual, 2024-10-31) — Interest Expense: 39000.00
CCJI.L income_statement (annual, 2024-10-31) — Interest Income: 79000.00
CCJI.L cash_flow (annual, 2024-10-31) — Interest Paid Cff: -322000.00
CCJI.L cash_flow (annual, 2024-10-31) — Investing Cash Flow: -476000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Investmentin Financial Assets: 258478000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Investmentin Financial Assets: 258478000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Investments And Advances: 258478000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 258478000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income: 37931000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 37931000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 37931000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 37931000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 37931000.00
CCJI.L cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 39190000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 37931000.00
CCJI.L income_statement (annual, 2024-10-31) — Net Interest Income: 40000.00
CCJI.L cash_flow (annual, 2024-10-31) — Net Investment Purchase And Sale: -476000.00
CCJI.L cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 0.00
CCJI.L balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 265841000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 265841000.00
CCJI.L income_statement (annual, 2024-10-31) — Normalized Income: 37931000.00
CCJI.L cash_flow (annual, 2024-10-31) — Operating Cash Flow: 11672000.00
CCJI.L income_statement (annual, 2024-10-31) — Operating Revenue: 39910000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 134730610.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 134730610.00
CCJI.L income_statement (annual, 2024-10-31) — Other Operating Expenses: 292000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Other Payable: 17000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Other Payable: 17000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Payables: 17000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Payables: 17000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Prepaid Assets: 42000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 42000.00
CCJI.L income_statement (annual, 2024-10-31) — Pretax Income: 38859000.00
CCJI.L cash_flow (annual, 2024-10-31) — Purchase Of Investment: -63521000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Receivables: 11854000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Receivables: 11854000.00
CCJI.L cash_flow (annual, 2024-10-31) — Sale Of Investment: 63045000.00
CCJI.L income_statement (annual, 2024-10-31) — Selling General And Administration: 759000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Share Issued: 134730610.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Share Issued: 134730610.00
CCJI.L balance_sheet (annual, 2024-10-31) — Stockholders Equity: 265841000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 265841000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Tangible Book Value: 265841000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 265841000.00
CCJI.L income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
CCJI.L income_statement (annual, 2024-10-31) — Tax Provision: 928000.00
CCJI.L income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.02
CCJI.L balance_sheet (annual, 2024-10-31) — Taxes Receivable: 193000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Taxes Receivable: 193000.00
CCJI.L cash_flow (annual, 2024-10-31) — Taxes Refund Paid: -928000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Total Assets: 274986000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Total Assets: 274986000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 265841000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 265841000.00
CCJI.L balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 9145000.00
CCJI.L balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 9145000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 98067000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Capital Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 2315000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Federal Funds Sold: -4363000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Common Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 268377000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 263325000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 263325000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 263325000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 268377000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 134730610.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Other Payable: 2734000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Payables: 2734000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Receivables: 12477000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Share Issued: 134730610.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 268377000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 268377000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Total Assets: 271439000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 268377000.00
CCJI.L balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 3062000.00
CCJI.L income_statement (annual, 2025-10-31) — +Operating Expense: 1358000.00
CCJI.L income_statement (annual, 2025-10-31) — +Total Revenue: 68008000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 98067000.00
CCJI.L income_statement (annual, 2025-10-31) — Basic Average Shares: 134730610.00
CCJI.L income_statement (annual, 2025-10-31) — Basic EPS: 0.49
CCJI.L cash_flow (annual, 2025-10-31) — Beginning Cash Position: 4006000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Capital Stock: 1348000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 4359000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 4359000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 5018000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 5018000.00
CCJI.L cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -7410000.00
CCJI.L cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: 0.00
CCJI.L cash_flow (annual, 2025-10-31) — Change In Payable: 49000.00
CCJI.L cash_flow (annual, 2025-10-31) — Change In Receivables: -367000.00
CCJI.L cash_flow (annual, 2025-10-31) — Change In Working Capital: -318000.00
CCJI.L cash_flow (annual, 2025-10-31) — Changes In Cash: 353000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Common Stock: 1348000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Common Stock: 1348000.00
CCJI.L cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -7410000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Common Stock Equity: 324049000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 324049000.00
CCJI.L income_statement (annual, 2025-10-31) — Diluted Average Shares: 134730610.00
CCJI.L income_statement (annual, 2025-10-31) — Diluted EPS: 0.49
CCJI.L income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 65618000.00
CCJI.L cash_flow (annual, 2025-10-31) — End Cash Position: 4359000.00
CCJI.L balance_sheet (annual, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 315369000.00
CCJI.L balance_sheet (quarterly, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 315369000.00
CCJI.L cash_flow (annual, 2025-10-31) — Financing Cash Flow: -7911000.00
CCJI.L cash_flow (annual, 2025-10-31) — Free Cash Flow: -1568000.00
CCJI.L cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: -67381000.00